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ABSTRACT 
Synthesis of a series of various 1-(6-bromobenzo[d]thiazol-2-yl)-2-(disubstitutedmethylene)hydrazine derivatives (7a-7e)have been done. 
Synthesis of a series of intermediates (3 and 5) have been also done, 6-bromo-1,3-benzothiazole-2-amine (3), 2-hydrazino-6-bromo-1, 3-
benzothiazole (5) and final product (7a-7e), 1-(6-bromobenzo[d]thiazol-2-yl)-2-(diphenylmethylene) hydrazine (7a), 1-(6-bromobenzo 
[d]thiazol-2-yl)-2-(propan-2-ylidene) hydrazine (7b), (E)-2-(butan-2-ylidene)-1-(6-bromobenzo[d]thiazol-2-yl)hydrazine (7c), (Z)-1-(6-
bromobenzo[d]thiazol-2-yl)-2-(cyclohexylmethylene) hydrazine (7d), 2-(6-bromobenzo[d]thiazol-2-yl)-1-(7,7- dimethylbicyclo [2.2.1] heptan-
2-ylidene)hydrazine (7e). Spectral analysis of all intermediates and final products has been done by IR and NMR. After spectral analysis, 
antibacterial activity has been screened against S. aurius and E. coli bacterias.  
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1. INTRODUCTION 
Antimicrobial agents are those which treat infection by 
suppressing or destroying the causative microorganisms 
such as bacteria, mycobacteria, fungi, protozoa or viruses 
without significant effect on host tissues1. 
Anti-microbial agents can be broadly classified as follows2 
(Figure 1) 
Nitrogen containing heterocyclic compounds specially azole 
family has the subject of continuous favourable interest in 
synthesis and owing to the fact that they occur 
pharmacologically active natural products, multipurpose 
oriented functional material3.  
Benzothiazoles have most interesting biophore in research 
because it is used as a synthon for the synthesis of 
biologically active structures4. 
 
 
Figure 1 
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Benzothiazole is present in compounds which are involved 
in research aimed for new products that having interesting 
biological activities such as antitumor5, antimicrobial6, anti-
inflammatory, anti-tubercular, anti-HIV7, anti-malarial8 and 
anti-convulsant9. 
A series of various derivatives of final products 1-(6-
bromobenzo[d]thiazol-2-yl)-2-(diphenylmethylene) 
hydrazine (7a), 1-(6-bromobenzo [d]thiazol-2-yl)-2-
(propan-2-ylidene) hydrazine (7b), (E)-2-(butan-2-ylidene)-
1-(6-bromobenzo[d]thiazol-2-yl)hydrazine (7c), (Z)-1-(6-
bromobenzo[d]thiazol-2-yl)-2-(cyclohexylmethylene) 
hydrazine (7d), 2-(6-bromobenzo[d]thiazol-2-yl)-1-(7,7- 
dimethylbicyclo [2.2.1] heptan-2-ylidene)hydrazine (7e) has 
been synthesized by placing 2-Hydrazino amino 
benzothiazole and ketone compound (6a-e) in equimolar 
conc. in a RBF. Ethanol (20 ml) was added in the mixture and 
the reaction mixture was refluxed for 10-15 hrs. All the 
compounds synthesized have been characterized by spectral 
data and antibacterial activity has been done against 
Gram+ve S. aurius and Gram-ve E. coli bacterias by standard 
procedure using broth dilution method and minimum 
inhibitory concentration was determined by visual 
comparison with the negative control tubes. 
2. EXPERIMENTAL 
2.1 Synthesis of 6-Chloro-1,3-benzothiazole-2-amine (3)
 
Br
NH2
+ KSCN
Glacial Acetic Acid
Br2 (10-15
0C)
S
N
NH2
Br
 
                                  1                                    2                                                           3 
Figure 2: Synthesis of 6-bromo-2-amino-1,3-benzothiazol 
 
Procedure:10 
Triturate the mixture of p-bromo aniline (20g,0.156 moles) 
and potassium thiocyanate (18.19g, 0.187 moles) in motor 
pastle for 10-15 min. Add cold acetic acid (50ml) in to motor 
and transfer this mixture in RBF, stirred  the mixture at 10-
15⁰C then add cold acetic bromine mixture (10ml acetic acid 
and bromine) in 2-3 hr. After completion of bromine 
addition stirred the mixture for 10-15 minute. The reaction 
was monitored by TLC. Remove the RBF and keep overnight 
in to freeze.  
Work up 
In the overnight reaction mixture add 10ml H2O and 5ml 
acetic acid. Heat the reaction mixture till cease of pungent 
smell of acetic acid. Cool this mixture and filter, the solid was 
removed and liquid was collected. The liquid was neutralize 
with ammonia dropwise at 5-10⁰C. The precipitated solid 
was collected by filtration. The white solid was collected as 
pure product. 
Yield                       : 85.76% 
Melting point       : 60-620C 
TLC                         : Silica gel G; Hexane: Ethyl acetate (1:1) 
                                    Rf = 0.726 
IR (Spectrum 1) : 3838, 3617, 2160, 1942, 1810, 1748, 
1634, 1557, 1473, 1396, 1304, 809 Cm-
1         
 
2.2 Synthesis of 2-hydrazino-6-bromo-1, 3-benzothiazole   (5)    
S
N
NH2
Br
+ NH2NH2.H2O
Conc.Hcl
Ethylene glycol
S
N
NH.NH2
Br  
3                                                        4                                                                                                   5 
Figure 3: Synthesis of 2-hydrazino-6-bromo-1,3-benzothiazole 
Procedure:11 
The obtained compound of  3a (5.00 gm,0.0264 moles) was 
dissolved in ethylene glycol (20 ml ) and Conc. Hcl (10 ml) 
was added drop by drop in this mixture,now cold hydrazine 
hydrate(10 ml)  was added in this mixture.The reaction 
mixture was refluxed for 15 hr. 
Work up: 
Cool the mixture and pour this reaction mixture in to 
crushed ice.The precipitate was obtained and the 
precipitated compound was filtered under vacuum. 
 
Yield                      : 83.23% 
Melting point      : 55-58⁰C 
TLC                        : Silica gel G; Hexane: Ethyl acetate (1:1) 
                                  Rf = 0.712 
IR (Spectrum 2)      : 3736, 3674, 2360, 1662, 1557, 1521, 
1473, 1396, 1338, 1211 Cm-1 
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2.3 Synthesis of final products (7a-e) 
General scheme 
Br S
N
NHNH2 + C O
R1
R2
Ethanol
Reflux
S
N
NHN
R1
R2
Br  
5                                                           6a-e                                             7a-e 
Figure 4: General synthetic scheme for final product 
 
Procedure:12 
The obtained compound 2-Hydrazino amino benzothiazole 
and ketone compound (6a-e) was taken in equimolar conc. 
in a RBF. Ethanol (20 ml) was added in the mixture and the 
reaction mixture was refluxed for 10-15 hrs. The reaction 
was monitored by TLC. 
Work up: 
Cool the mixture, the precipitate was collected. The product 
was purified by column chromatography (Ethylacetate: 
hexane) to give the final product. 
 
Sr. No. Compound Name R1 R2 
1 7a 1-(6-bromobenzo[d]thiazol-2-yl)-2-
(diphenylmethylene) hydrazine 
-C6H5 -C6H5 
2 7b 1-(6-bromobenzo [d]thiazol-2-yl)-2-(propan-
2-ylidene) hydrazine 
-CH3 -CH3 
3 7c (E)-2-(butan-2-ylidene)-1-(6-
bromobenzo[d]thiazol-2-yl)hydrazine 
-CH3 -C2H5 
Table 1 
 
(Z)-1-(6-bromobenzo[d]thiazol-2-yl)-2-(cyclohexylmethylene) hydrazine (7d). 
 
2-(6-bromobenzo[d]thiazol-2-yl)-1-(7, 7- dimethylbicyclo [2.2.1] heptan-2-ylidene)hydrazine (7e). 
 
2.3.1. Synthesis of 1-(6-bromobenzo[d]thiazol-2-yl)-2-(diphenylmethylene) hydrazine (7a): 
Br S
N
NHNH2 + C O
C6H5
C6H5
Ethanol
Reflux
S
N
NHN
C6H5
C6H5
Br  
5                                                6a                                                                 7a 
Figure 5: Synthesis of 1-(6-bromobenzo[d]thiazol-2-yl)-2-(diphenylmethylene)hydrazine 
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Procedure12 
The obtained compound 2-Hydrazino amino benzothiazole 
(0.5gm,0.0024moles) and benzophenone 
(0.43gm,0.0024moles) was taken in a RBF. Ethanol (20 ml) 
was added in the mixture and the reaction mixture was 
refluxed for 10-15 hrs.The reaction was monitored by TLC. 
Cool the mixture, the precipitate was collected. The product 
was purified by column chromatography. 
 
Yield                  : 83.27% 
Melting point  : 55-57⁰C 
TLC                   : Silica gel G; Hexane: Ethyl acetate (7:3) 
                              Rf = 0.583 
IR (Spectrum 3): 3864, 3674, 3587, 2926, 2399, 1733, 1698, 
1557, 1507, 1473 Cm-1
 
2.3.2. Syntesis of 1-(6-bromobenzo[d]thiazol-2-yl)-2-(propan-2-ylidene) hydrazine (7b): 
Br S
N
NHNH2 + C O
H3C
H3C
Ethanol
Reflux
S
N
NHN
CH3
CH3
Br                        
5                                             6b                                                           7b 
Figure 6: Synthesis of 1-(6-bromobenzo[d]thiazol-2-yl)-2-(propan-2-ylidene) hydrazine 
 
Procedure12 
The obtained compound 2-Hydrazino amino-6-bromo-1,3-
benzothiazole (compound 5) (0.5gm,0.0024moles) and 
acetone  (0.176ml,0.0024moles) was taken in a RBF. Ethanol 
(20 ml) was added in the mixture and the reaction mixture 
was refluxed for 10-15 hrs. The reaction was monitored by 
TLC. Cool the mixture, the precipitate was collected. The 
product was purified by column chromatography. 
Yield                  : 81.84% 
Melting point     : 55-57⁰C 
TLC                   : Silica gel G; Hexane: Ethyl acetate (7:3) 
                              Rf = 0.554 
IR (Spectrum 7): 3710, 3679, 3597, 2360, 1697, 1662, 1558, 
1521, 1362, 1288 Cm-1 
 
 
2.3.3. Synthesis of (E)-2-(butan-2-ylidene)-1-(6-bromobenzo[d]thiazol-2-yl)hydrazine (7c): 
Br S
N
NHNH2 + C O
H3C
Ethanol
Reflux
S
N
NHN
CH3
C2H5
Br
C2H5
                         
5                                        6c                                                                                7c 
Figure 7: Synthesis of (E)-2-(butan-2-ylidene)-1-(6-bromobenzo[d]thiazol-2-yl)hydrazine 
 
Procedure12 
The obtained compound 2-Hydrazino amino benzothiazole 
(0.5gm,0.0024moles) and Ethyl methyl ketone 
(0.215ml,0.0024moles) was taken in a RBF. Ethanol (20 ml) 
was added in the mixture and the reaction mixture was 
refluxed for 10-15 hrs.The reaction was monitored by TLC. 
Cool the mixture, the precipitate was collected. The product 
was purified by column chromatography. 
Yield                  : 86.97% 
Melting point     : 55-60⁰C 
TLC                   : Silica gel G; Hexane: Ethyl acetate (7:3) 
                              Rf = 0.578 
IR (Spectrum 5): 3648, 3587, 2871, 2359, 1844, 1771, 1733, 
1670, 1635, 1557 cm-1 
1H NMR (Spectrum 6): δ ppm 9.5 (bs, 1H, -NH-), 7.68-7.27 
(m, 3H, Ar-H), 2.09 (s, 3H, N=C-CH3), 2.37-2.20 (q, 2H, N=C-
CH2-CH3), 1.11-1.04 (t, 3H, N=C-CH2-CH3). 
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2.3.4. Synthesis of (Z)-1-(6-bromobenzo[d]thiazol-2-yl)-2-(cyclohexylmethylene) hydrazine (7d) 
S
N
NHN
Br
Br S
N
NHNH2 +
Ethanol
Reflux
O
  
5                                              6d                                                                     7d 
Figure 8: Synthesis of (Z)-1-(6-bromobenzo[d]thiazol-2-yl)-2-(cyclohexylmethylene) hydrazine 
 
Procedure12 
The obtained compound 2-Hydrazino amino benzothiazole 
(0.5gm,0.0024moles) and Cyclohexanone 
(0.248ml,0.0024moles) was taken in a RBF. Ethanol (20 ml) 
was added in the mixture and the reaction mixture was 
refluxed for 10-15 hrs. The reaction was monitored by TLC. 
Cool the mixture, the precipitate was collected. The product 
was purified by column chromatography. 
Yield                  : 81.84% 
Melting point  : 55-57⁰C 
TLC                   : Silica gel G; Hexane: Ethyl acetate (7:3) 
                              Rf = 0.554 
IR (Spectrum 7): 3710, 3679, 3597, 2360, 1697, 1662, 1558, 
1521, 1362, 1288 Cm-1 
 
2.3.5 . Synthesis of (E)-2-(6-bromobenzo[d]thiazol-2-yl)-1-(7,7-dimethylbicyclo[2.2.1] heptan-2-ylidene)hydrazine 
(7e): 
Br S
N
NHNH2+
N
NH
S
N
Br
O  
                              5                                               6e                                                                              7e 
Figure 9: Synthetic scheme of 2-(6-bromobenzo[d]thiazol-2-yl)-1-(7,7-dimethylbicyclo [2.2.1] heptan-2-
ylidene)hydrazine 
 
Procedure12 
The obtained compound 2-Hydrazino amino benzothiazole 
(0.5gm,0.0024moles) and Camphor (0.365gm,0.0024moles) 
was taken in a RBF. Ethanol (20 ml) was added in the 
mixture and the reaction mixture was refluxed for 10-15 
hrs.The reaction was monitored by TLC. Cool the mixture, 
the precipitate was collected. The product was purified by 
column chromatography. 
 Yield                  : 83.77% 
Melting point   : 55-58⁰C 
TLC                     : Silica gel G; Hexane: Ethyl acetate (7:3) 
                              Rf = 0.585 
IR (Spectrum 8): 3706, 3545, 3480, 3429, 3321, 2852, 1591, 
1522, 1436, 1418, 817Cm-1 
3. BIOLOGICAL SCREENING 
Anti-microbial testing  
Activity of anti-infective agents may be demonstrated under 
suitable conditions by their inhibitory effect on 
microorganisms. The anti-microbial activity of the 
synthesized compounds was carried out by standard 
procedure using broth dilution method and minimum 
inhibitory concentration was determined by visual 
comparison with the negative control tubes.  
Detailed test procedure 
(i) Stock Solutions of test compounds and standard drug 
Compounds were taken as test samples along with a 
standard Streptomycin sample. Weight taken in the range of 
8-20 mg of each test compound and was dissolved in 1 ml of 
DMSO. For preparing stock solution of Streptomycin, 10 mg 
of Streptomycin was dissolved in 1 ml of water.    
(ii) Test organism 
The organisms employed in the in vitro testing of the 
compounds wereEscherichia coli and S. aureus. All the 
cultures were maintained on nutrient broth agar 
(Microbiology grade, CDH Pvt. Ltd. New Delhi) medium by 
periodic sub culturing. 
(iii) Preparation of Innoculum 
Procedure for the preparation of innoculum for both the 
strains was same. The innoculum was prepared from a 24-
hours old growth of organism on nutrient broth agar slant. 
To the agar slant, saline solution was added to obtain O.D 
value of 0.1 on photoelectric optical colorimeter. 0.5ml of 
this solution was further diluted to 20ml with use of saline.  
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(iv) Preparation of Medium 
1.3 gms of nutrient broth (Microbiology grade, CDH Pvt. Ltd. 
New Delhi.) was dissolved in 100 ml of sterile distilled 
water.  
(v) Addition of drug, innoculum solution to medium 
From diluted innoculum solution prepared, 100μl was added 
to separate test tube each containing 0.9ml of medium. 25 μl 
solution of test stock solution was added in four separate 
test tube containing 0.9ml of medium with 100 μl 
innoculum. The tests were carried out in duplicate. Apart 
from putting the controls of standard drug (Streptomycin), 
controls with dimethylsulphoxide (DMSO) were used. DMSO 
(positive control) is DMSO inoculated with organisms and 
dimethylsulphoxide (negative control) is plain DMSO. For 
incubation, test tubes were kept in incubator at 35°C for 24 
hours.  
(vi) Observations 
At the end of incubation period, the results were interpreted 
by comparison with negative control. The lowest 
concentration of test compound which showed inhibitory 
effect on growth on visual distinction was taken as minimum 
inhibitory concentration (MIC) and visual turbidity was 
consider for MIC of the test molecules; standard drug and 
DMSO positive and negative control visual turbidity were 
recorded. 
4. RESULT AND DISCUSSIONS 
4.1 Characterization of the benzothiazole derivatives 
IR:  The spectrum showed characteristic absorption band 
accordingly of the presence of functional group. The Ar-C-H 
stretching showed the absorption band in the range of 3010-
3150 cm-1. The –C=N stretching band appeared in the range 
of 1630-1660 cm-1, -C=C- stretching peak comes in the range 
of 1400-1500 cm-1, alkyl C-H stretching peak comes in the 
range of 2820-2860 cm-1.  N-H stretching band was 
appeared in the range of 3150-3300 cm-1 
One representative molecule Compound 7c was 
characterized 1H NMR spectroscopy. 
1H NMR: The methyl protons appeared as a singlet at around 
δ 2.09. The methylene protons appeared as a singlet at 
around δ 2.37-2.20. The aromatic protons appeared as 
multiple singlets between δ 7.22-7.59. The N-H proton 
appeared at 9.5 as a singlet. Representative example is 7c. 
Table 2: Comparison of 1H NMR values 
Sr. No. No of proton 
Predicted 
(δ in ppm) 
Experimental 
(Spectrum 6) 
1 -CH3 2.0 2.09 
2 -N=C-CH2-CH3 1.4 2.37-2.2 
3 -N=C-CH2-CH3 0.9 1.11-1.04 
 Ar-H 7.77-8.29 7.22-7.59 
 
4.2 Biological evaluation 
The synthesized NCEs were subjected to antimicrobial 
evaluation against Escherichia coli and S. aureus 
microorganism using broth dilution method keeping 
appropriate positive and negative controls simultaneously.  
Visual turbidity of evaluated compounds is given in Table 3 
 
Table 3: Visual turbidity of evaluated compounds 
Sr. No. Compounds Visual Turbidity            
(E. Coli) 
Visual Turbidity          
(S. Aureus) 
1. 7a - - 
2. 7b - - 
3. 7c + + 
4. 7d - - 
5. 7e - + 
6. Streptomycin - - 
7 DMSO positive ++ ++ 
- = No Turbidity (No bacterial growth), + = Turbidity (Bacterial growth) 
 
Based on the visual turbidity, the  MIC of the evaluated 
molecules is given in Table 3 the evaluation concentration 
was used single therefore, the exact MIC could not 
determined and results are represented in less than and 
more than format. To get more exact MIC of the tested 
molecules need to be evaluated at low concentration. The 
evaluation results of the single concentration is tabulated in 
Table 4 
Sr. No. Compounds  E. coli 
 (µg/ml) 
 S. aureus 
(µg/ml) 
1. 7a <12.5 <12.5 
2. 7b <12.5 <12.5 
3. 7c >12.5 >12.5 
4. 7d <12.5 <12.5 
5. 7e <12.5 >12.5 
6. Streptomycin <6.25 <6.25 
Table 4 
4.3 Result of antibacterial testing 
Most of the tested compounds had bacterial growth 
inhibition activity at tested concentration against both of 
microorganisms. Compounds 7a, 7b, 7d and 7e exhibited 
growth inhibition of E.coli while 7c didn't show activity. The 
compound 7a, 7b and 7d showed the inhibition of S. aureus. 
5. CONCLUSION 
Thus, it can be concluded that designed benzothiazole 
derivatives were synthesized successfully and compound 7a-
7e had antibacterial activity at tested concentration less than 
1000µg per ml. and compound 7a exhibited activity at lower 
concentration less than 200µg per ml. Compound 7c didn't 
show activity at higher concentration upto 1000µg per ml. 
against both Gram+ve and Gram -ve microorganisms. So, 
synthesized benzothiazole derivatives can act as a lead for 
development of broad spectrum antibacterial agents.
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6. SPECTRAS 
 
Spectrum 1: IR Spectra of 3 
 
 
Spectrum 2: IR Spectra of 5 
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Spectrum 3: IR Spectra of 7a 
 
Spectrum 4: IR Spectra of 7b 
 
Spectrum 5: IR Spectra of 7c 
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Spectrum 6: IR Spectra of 7c 
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Spectrum 8: IR Spectra of 7e 
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